Cotinga Pharmaceuticals Inc (COTh)

TSXV
0.2750
0.0000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.2750/0.2800
  • Day's Range:
    0.2650 - 0.2950
Trading near 52-week High

Cotinga Pharma has hit the highest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

COTh Overview

Prev. Close
0.275
Day's Range
0.265-0.295
Revenue
-
Open
0.295
52 wk Range
0.035-0.035
EPS
-0.12
Volume
0
Market Cap
769.52K
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
19,001
P/E Ratio
-
Beta
1.63
1-Year Change
685.71%
Shares Outstanding
21,986,415
Next Earnings Date
-
What is your sentiment on Cotinga Pharma?
or
Market is currently closed. Voting is open during market hours.

Cotinga Pharmaceuticals Inc News

Cotinga Pharmaceuticals Inc Analysis

Cotinga Pharmaceuticals Inc Company Profile

Cotinga Pharmaceuticals Inc Company Profile

Employees
6
Market
Canada
  • Type:Equity
  • Market:Canada
  • ISIN:CA22164W1059
  • CUSIP:22164W105

Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company’s lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent’s University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving Averages
Technical Indicators
Summary